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Avian leukosis virus subgroup J (ALV-J) is an oncogenic retrovirus that has a similar
replication cycle to multiple viruses and therefore can be used as a model system for
viral entry into host cells. However, there are few reports on the genes or microRNAs
(miRNAs) that are responsible for the replication of ALV-J. Our previous miRNA and
RNA sequencing data showed that the expression of miR-34b-5p was significantly
upregulated in ALV-J-infected chicken spleens compared to non-infected chicken
spleens, but melanoma differentiation-associated gene 5 (MDA5) had the opposite
expression pattern. In this study, a dual-luciferase reporter assay showed that MDA5 is
a direct target of miR-34b-5p. In vitro, overexpression of miR-34b-5p accelerated the
proliferation of ALV-J-infected cells by inducing the progression from G2 to S phase
and it promoted cell migration. Ectopic expression of MDA5 inhibited ALV-J-infected
cell proliferation, the cell cycle and cell migration, and knockdown of MDA5 promoted
proliferation, the cell cycle and migration. In addition, during ALV-J infections,MDA5 can
detect virus invasion and it triggers the MDA5 signaling pathway. MDA5 overexpression
can activate the MDA5 signaling pathway, and thus it can inhibit the mRNA and protein
expression of the ALV-J env gene and it can suppress virion secretion. In contrast, in
response to the knockdown ofMDA5 by small interfering RNA (siRNA) or an miR-34b-5p
mimic, genes in theMDA5 signaling pathwaywere significantly downregulated (P< 0.05),
but the mRNA and protein expression of ALV-J env and the sample-to-positive ratio
of virion in the supernatants were increased. This indicates that miR-34b-5p is able to
trigger the MDA5 signaling pathway and affect ALV-J infections. Together, these results
suggest that miR-34b-5p targets MDA5 to accelerate the proliferation and migration of
ALV-J-infected cells, and it promotes ALV-J replication, via the MDA5 signaling pathway.
Keywords: MiR-34b-5p, melanoma differentiation-associated gene 5 (MDA5), Avian leukosis virus subgroup J
(ALV-J), Cell proliferation, MDA5 signaling pathway
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INTRODUCTION
Avian leukosis virus subgroup J (ALV-J) is a novel, virulent
subtype in the avian leukosis virus family (ALVs), which can
be classified into 10 subgroups (Payne, 1998). In birds, ALV-J
can induce myeloid leukosis, various tumors, growth retardation,
and serious immunosuppression (Stedman and Brown, 1999;
Payne and Nair, 2012; Zeng et al., 2014). There is no effective
vaccine against ALV-J (Payne and Nair, 2012). Furthermore,
as an oncogenic retrovirus, ALV-J shares a similar replication
cycle with a number of RNA and DNA viruses, such as human
immunodeficiency virus type-1 (HIV-1), which can replicate
in both the nucleus and the cytoplasm. Therefore, it can be
used as a model system for viral entry into host cells. Thus,
identifying the pathogenic mechanism of ALV-J can provide a
solid foundation for further study of other retroviruses. Recently,
several genes and the extracellular signal-regulated kinase
(ERK)/ mitogen-activated protein kinase (MAPK) pathway have
been demonstrated to be important for ALV-J replication and
oncogenesis (Chai and Bates, 2006; Li Y. et al., 2014; Dai
et al., 2016). However, the microRNAs (miRNAs) and pathways
involved in ALV-J infections largely remain unclear.
MiRNAs are small non-coding RNAs that play important
roles in cell growth, proliferation, and apoptosis by inducing
translational inhibition or mRNA degradation (Sun et al., 2010;
Feng et al., 2011). Aberrant expression of miRNAs has been
linked to tumorigenesis (Zhao et al., 2009; Datta et al., 2012). To
date, the expression of several miRNAs has been found to change
in response to ALV-J infection. For example, four miRNAs (gga-
miR-125b, gga-miR-193a, gga-miR-193b, and gga-miR-221) that
are known to be involved in tumorigenesis-related pathways were
shown to be expressed abnormally in ALV-J-infected chickens,
and they might be associated with ALV-J-induced tumorigenesis
(Wang et al., 2013a). It has been shown that the binding of gga-
miR-1650 to several sites in the 5′ untranslated region (UTR) of
ALV-J genomic RNA is critical for viral replication (Wang et al.,
2013b). In addition, gga-miR-221, gga-miR-222, and gga-miR-
375 have been shown to play a pivotal role in tumorigenesis after
an ALV-J infection (Li H. et al., 2014; Dai et al., 2015).
We previously showed that miRNA-23b promotes ALV-J
replication by targeting interferon regulatory factor-1 (IRF1; Li
et al., 2015). The miRNA sequencing data (Gene Expression
Omnibus; GEO database, accession number GSE63676) also
showed that another miRNA, gga-miR-34b-5p, was upregulated
in ALV-J-infected chickens compared to non-infected chickens,
suggesting that this miRNA might also be involved in ALV-J
infections. In humans, miR-34b has been reported to be involved
in many neoplastic diseases and low levels of expression of miR-
34b were found to be associated with gastric tumorigenesis (Tsai
et al., 2011).
Vertebrate innate immune responses are mediated by pattern
recognition receptors (PRRs), including Toll-like receptors
(TLRs), retinoic acid-inducible gene I-like receptors (RLRs),
and Nod-like receptors (NLRs). MDA5 is a member of the
RLR family, which are comprised of N-terminal tandem caspase
activation and recruitment domains (CARDs), a central helicase
domain responsible for RNA-dependent ATP hydrolysis and
a C-terminal regulatory domain (CTD; Kato et al., 2006).
Moreover, MDA5 can activate the interferon (IFN) signaling
pathway and it thereby plays a critical role in antiviral innate
immunity. Our previously published RNA sequencing data
(GSE63226) showed that MDA5 was downregulated in ALV-J-
infected chickens compared to non-infected chickens. However,
relatively little is known regarding the effect of ectopic expression
ofMDA5 in ALV-J-infected chickens.
The first aim of this study was to explore whether or not miR-
34b-5p is involved in ALV-J infections and to clarify how it affects
ALV-J replication, as well as to characterize the oncogenesis
in chicken fibroblast cell line (DF-1) infected with ALV-J. We
confirmed that miR-34b-5p was increased in ALV-J-infected
tissues and that ectopic expression of miR-34b-5p accelerated
the proliferation and migration of ALV-J-infected cells. MDA5
was verified as a direct target of miR-34b-5p. Further in vitro
investigations demonstrated that miR-34b-5p can regulate the
MDA5 signaling pathway, the expression of the ALV-J Env gene,
and virion secretion. Taken together, these results suggest that
miR-34b-5p accelerates the proliferation and migration ALV-
J-infected cells and promotes ALV-J replication by targeting
MDA5.
MATERIALS AND METHODS
Ethics Statement
All animal experiments in this study were performed following
protocols approved by the Institutional Animal Care and Use
Committee at the South China Agricultural University, China
(approval ID: SCAU#0011). All the experiments were carried out
in compliance with the regulations and guidelines established by
this committee. The authors declare that all animal experiments
under the consent of the animal owners. All efforts were made to
minimize suffering to animal. The authors declare no additional
considerations of the study in cases where vulnerable populations
were involved.
Animals
Two chicken groups, ALV-J-infected broilers and non-infected
broilers at 140 days old, were used. The animals were the same
as those used in our previous RNA sequencing study (Li et al.,
2015).
Virus Propagation and Quantification of
Virus Titer
SCAU-HN06, a strain of ALV-J, was kindly provided by Assoc.
Prof. Weisheng Cao (South China Agricultural University).
The chicken embryonic fibroblast cell line (DF-1 cells) was
obtained from the Cell Bank of the Committee on Type Culture
Collection of the Chinese Academy of Sciences and it was
cultivated adherently in cell culture vessels containing Dulbecco’s
Modified Eagle’s Medium (DMEM; Gibco, Life Technologies,
Grand Island, NY, USA) supplemented with 10% fetal bovine
serum (FBS; Gibco, Life Technologies, Grand Island, NY, USA)
at 37◦C in an atmosphere of 5% CO2. When the cells grew
to a density of 80% confluence, they were infected with the
ALV-J strain SCAU-HN06. The inoculum was discarded 2 h
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 January 2017 | Volume 7 | Article 17
Li et al. MiR-34b-5p Promotes ALV-J Replication
later and it was replaced with DMEM containing 1% FBS, 100
U/mL penicillin, and 100 ug/mL streptomycin. After incubation
for 6 days in culture, the cell supernatants (which contained
the viral particles) were harvested as described previously (Dai
et al., 2016). The virus was diluted 10-fold using serial dilution
techniques in DMEM and the suspension was then applied to
DF-1 cells for 6 days in a 96-well plate. The virus was titrated
to determine the 50% tissue culture infectious doses (TCID50)
in accordance with the method described by Reed and Muench
(1938).
RNA Isolation and cDNA Synthesis
Total RNA was extracted from the tissue samples and DF-1 cells
using TRIzol R© as recommended by the supplier (Invitrogen Life
Technologies, Carlsbad, CA, USA). The integrity and quantity of
RNA were assessed using 1.5% agarose gel electrophoresis and
spectrophotometry (ND-2000, NanoDrop Inc., Wilmington, DE,
USA), respectively. A PrimeScript RT Reagent Kit (Takara, Otsu,
Japan) was used to carry out cDNA synthesis of mRNA, following
the manufacture’s protocol. The synthesized cDNA was stored
at −20◦C until subsequent analysis using real-time quantitative
polymerase chain reaction (RT-qPCR).
Primers
RT-qPCR primers that were specific for MDA5, ALV-J Env,
Gag, Pol, Mx1, and β-actin were designed using Premier Primer
5.0 software. RT-qPCR primers that were specific for genes in
the MDA5 signaling pathway, including interferon-β promoter
stimulator 1 (IPS-1), interferon regulatory factor-3 (IRF-3),
interferon-β (IFNβ), double-stranded RNA-dependent protein
kinase (PKR), 2′, 5′-oligoadenylate synthetase (OAS), myxovirus
(influenza virus) resistance 1, interferon-inducible protein p78
(mouse) (Mx1), and major histocompatibility complex class
I (MHC class I), are referenced in previous publications
(Supplementary Table 1; Lee C. C. et al., 2014). PCR primers for
the full-length MDA5 coding sequence clone and the 3′ UTR of
the MDA5 clone were also designed using the Premier Primer
5.0 software (Supplementary Table 2). All the above primers were
synthesized by Sangon Biotech Co., Ltd. (Guangzhou, China).
A bulge-loopTM Reverse Transcription primer and RT-qPCR
primers that were specific for gga-miR-34b-5p were designed and
synthesized by RiboBio (Guangzhou, China).
RNA Oligoribonucleotides and Plasmids
Construction
Gga-miR-34b-5p mimics, mimic control duplexes, small
interfering RNA (siRNA) targeted against the MDA5 gene
(si-MDA5), and a non-specific siRNA control duplex were
designed and synthesized by RiboBio (Guangzhou, China).
Oligonucleotide sequences of si-MDA5 were showed in
Supplementary Table 3. To construct a gga-miR-34b-5p target
luciferase reporter vector (pmirGLO-WT MDA5-3′UTR), the
segment sequence of the MDA5 3′ UTR (666 bp) that contained
the putative gga-miR-34b-5p binding sequence was amplified
by PCR using a cDNA template synthesized from total RNA.
Subsequently, the PCR product was sub-cloned into NheI/SalI
restriction sites in the pmirGLO dual-luciferase reporter vector
(Promega, Madison, WI, USA) to generate the pmirGLO-
WT-MDA5-3′UTR reporter vector.
However, to generate a gga-miR-34b-5p target-mutated
reporter vector (pmirGLO-MT-MDA5-3′UTR), mutations
were achieved by changing the gga-miR-34b-5p binding seed
sequences from ACTGCCT to GACTATC using the megaprimer
PCR method (Ke and Madison, 1997). AnMDA5 overexpression
construct was generated by amplifying the MDA5 coding
sequence, and it was subsequently cloned into the overexpression
plasmid vector, pSDS-20218, which was purchased from
Shanghai SiDanSai Biotechnology Co., Ltd., China (http://www.
sidansai.com/).
Transfection of MDA5 Overexpression
Plasmid, si-MDA5, and miR-34b-5p Mimics
and Preparation of ALV-J
When DF-1 cells grew to a density of 50% confluence, they were
transfected with (a) the MDA5 overexpression plasmid, (b) si-
MDA5, or (c) the gga-miR-34b-5p mimic using Lipofectamine
3000 Reagent (Life Technologies, USA), in accordance with the
manufacture’s recommended protocol., After 12 h, the cells were
inoculated with TCID50 of ALV-J. After 2 h of incubation, the
supernatant was discarded and the infected cells were replenished
with DMEM medium containing 1% FBS, 100 U/mL penicillin,
and 100 ug/mL streptomycin.
Luciferase Reporter Assay
Luciferase activity was measured using Dual-GLO R© Luciferase
Assay System Kits (Promega, Madison, WI, USA) following
the manufacturer’s instructions. DF-1 cells were seeded at a
density of 1 × 103 cells per well in 96-well plates. After
24 h, the cells were co-transfected with 100 ng pmir-GLO-
WT-MDA5-3′ UTR- (wild-type) or pmir-GLO-MT-MDA5-3′
UTR(mutant-type) plasmids, or 100 nM gga-miR-34b-5p mimic
andmiR-NC using the Lipofectamine 3000 Reagent. Fourty-eight
hours after transfection, luciferase assays were performed using
a Fluorescence/Multi-Detection Microplate Reader (Synergy
2, Biotek, Winooski, VT, USA). The values obtained were
normalized to the levels of a Renilla luciferase plasmid (pRL-TK
Vector) levels.
RT-qPCR Analysis
The RT-qPCR reactions were performed using a Bio-Rad
CFX96 Real-Time PCR Detection System using iTaqTM Universal
SYBR R© Green Supermix Kits (Bio-Rad Laboratories Inc.,
Hercules, CA, USA) to detect the mRNA expression level
associated with each gene. The chicken β-actin gene was used
as an internal control. The analysis was carried out using the
2−11Ct method, as described previously (Livak and Schmittgen,
2001).
Wound Healing Assay
We also carried out a wound healing migration assay. First,
DF-1 cells were seeded in 12-well plates. When the cells grew
to a density of 50% confluence, they were transfected with the
MDA5 overexpression plasmid, si-MDA5, or a gga-miR-34b-5p
mimic, and then they were infected with ALV-J, as described
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above. When the cells reached a density of 100% confluence,
a linear wound was generated by scratching the monolayer of
cells with a 1 mL pipette tip. The cells that migrated into the
wound area were captured at 0 (control), 24, 48, and 72 h using
a microscope (Nikon, Shinagawa, Tokyo, Japan). Width of the
scratches was measured using the Image Pro Plus 6.0 software
(Media Cybernetics). The data of each scratch width were
presented in Supplementary Table 4. The formula to calculate the
cell migration rate was as follows: (W0h − Wxh) × 100%/W0h,
where W0h, represents the mean wound width at 0 h and Wxh
represents the mean wound width at 24, 48, and 72 h.
Flow Cytometry Analysis
For the flow cytometry analysis of the cell cycle, DF-1 cells were
seeded in 12-well plates. When the cells grew to a density of
50% confluence, they were transfected and then infected with
ALV-J, as described above. After being infected, the cells were
incubated for 72 h, collected and fixed overnight with 75%
ethanol at 4◦C. The fixed cells were stained with 50 µg/mL
propidium iodide solution (Sigma Life Science, St. Louis, MO,
USA) containing 10 µg/mL RNase A (Takare) and 0.2% (v/v)
Triton X-100 (Sigma), and they were incubated in the dark for
30 min at 37◦C. The cell cycle phase analysis of the incubated
cells was performed using a BD Accuri C6 flow cytometer (BD,
San Jose, CA, USA).
Sodium Dodecyl Sulfate Polyacrylamide
Gel Electrophoresis (SDS-PAGE) and
Western Blotting
SDS-PAGE andWestern blotting were performed using methods
that have been described in detail previously (Feng et al., 2016).
The primary antibodies used were as follows: ALV-J-specific
monoclonal antibody JE-9 (which was kindly provided by Prof.
Aijian Qin, Yangzhou University, China) and mouse polyclonal
anti-glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH;
Bioworld Technology, Inc., USA). Goat anti-rabbit IgG (heavy
and light chains (H+L))-horseradish peroxidase (HRP) and goat
anti-mouse IgG (H+L)-HRP (Bioworld Technology, Inc., USA)
served as secondary antibodies. The DF-1 cells were seeded in 6-
well plates. When the cells grew to a density of 50% confluence,
they were transfected, and then infected with ALV-J, as described
above. After 3 days in culture, the DF-1 cells were subjected to
the SDS-PAGE and Western blot analyses. Detection of HRP-
conjugated secondary antibodies was performed using Western
Lightning Chemiluminescence Reagent Plus (Perkin Elmer Life
Sciences, Inc, Boston, MA, USA), and images were developed on
X-ray films.
Enzyme-Linked Immunosorbent Assay
(ELISA)
For the ELISA, the DF-1 cells were seeded in 96-well plates.
When the cells grew to a density of 50% confluence, they were
transfected, and then infected with ALV-J, as described above. At
the indicated times (24, 48, 72, 96, and 120 h), the supernatants
were collected. After three repetitions of freezing and thawing
the supernatants, the ALV-J p27 protein expression level was
measured using an ELISA ALV-J diagnosis kit, as described in
the manufacturer’s protocol (IDEXX, USA).
Cell-Counting Kit-8 (CCK-8) Assay
For the cell growth assays, DF-1 cells were seeded in 96-well
plates. When the cells grew to a density of 50% confluence, they
were transfected, and then infected with ALV-J, as described
above. The viable cells were detected every 24 h using a
CKK-8 (Dojindo, Kumamoto, Japan), in accordance with the
manufacturer’s protocol. Absorbance was measured using a
Model 680 Microplate Reader (Bio-Rad, Hercules, California,
USA) by optical density at a wavelength of 450 nm.
Statistical Analysis
Each experiment was performed in triplicate. The data are
presented as the mean ± the standard error of the mean (SEM)
of each set of three independent experiments. Where applicable,
the statistical significance of the data was tested using one-sample
or paired t-tests. The types of tests and the P-values, when
applicable, are indicated in the figure legends.
RESULTS
MIR-34b-5p is Aberrantly Upregulated in
ALV-J-Infected Chickens
ALV-J, an oncogenic retrovirus, induces several leukemia-like
proliferative diseases in the hemopoietic systems of chickens.
Based on our previous miRNA sequencing data (GEO database
accession numbers, GSE63676), miR-34b-5p was found to be
significantly (P = 1.62E-71) upregulated in the spleens of ALV-
J-infected chickens compared to the spleens of non-infected
chickens (Figure 1A). In addition, RT-qPCR involving immune
system-related tissues showed that the expression of miR-34b-
5p was significantly increased (P = 0.0036 and P = 0.0197) in
ALV-J-infected spleens and thymuses compared to non-infected
spleens and thymuses, respectively (Figure 1B). In the liver, the
expression of miR-34b-5p was also increased in ALV-J-infected
chickens, although the difference was not significant (P = 0.09).
These findings demonstrate that the expression of miR-34b-5p
is significantly dysregulated in ALV-J-infected chickens and it
might be involved in virus invasion.
MIR-34b-5p Promotes Cell Proliferation
and Migration and Modulates Cell Cycle
Progression in ALV-J-Infected DF-1 Cells
Previous studies demonstrated that miRNAs can affect various
aspects of cancer biology, including cell proliferation, migration,
and apoptosis (Zhao et al., 2014; Shi W. et al., 2016). To explore
the role of miR-34b-5p on ALV-J infection, we investigated its
influence on cellular processes in ALV-J-infected cells. Firstly,
we transiently transfected an miR-34b-5p mimic or a negative
control mimic (empty plasmid; miR-NC) into DF-1 cells. After
12 h in culture media, the transfected DF-1 cells were infected
with ALV-J, and then cell proliferation and migration analyses
were carried out. The result of the CCK-8 assay showed that
overexpression of miR-34b-5p could significantly (at P < 0.05
or P < 0.01) promote the proliferation of ALV-J-infected
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FIGURE 1 | Relative expression of miR-34b-5p in ALV-J-infected and
non-infected tissues. (A) MiRNA sequencing showed that miR-34b-5p was
upregulated in the spleen of ALV-J-infected chickens. (B) RT-qPCR showed
that the expression of miR-34b-5p was increased in immune system-related
tissues (including the liver, spleen, and thymus) from ALV-J-infected chickens
compared to those from non-infected chickens. RT-qPCR data are expressed
as the fold change relative to the control (β-actin) gene. In both panels, each
bar represents the mean ± the SEM of three independent experiments.
Asterisks denote statistically significant differences: *, **, and *** indicate P <
0.05, P < 0.01, and P < 0.001, respectively. ALV-J, Avian leukosis virus
subgroup J; miRNA, microRNA; RT-qPCR, real-time quantitative polymerase
chain reaction; SEM, standard error of the mean.
cells compared to miR-34b-5p negative control (miR-NC) at
24∼96 h after the ALV-J infection (Figure 2A). Moreover, using
flow cytometry, we found that overexpression of miR-34b-5p
significantly increased the number of cells in S phase (P < 0.001)
and reduced the number of cells in G2 phase (P< 0.05) compared
to the negative control group (Figure 2B).
Subsequently, to assess the effect of miR-34b-5p
overexpression on the cell migration, a wound healing assay
was performed in ALV-J-infected DF-1 cells. We found that
the migration rate of DF-1 cells transfected with miR-34b-5p
mimics was significantly increased (P < 0.05 and P < 0.01 at
48 and 72 h after the ALV-J infection, respectively) compared
to the negative control group (Figures 2C,D). Taken together,
our data suggested that miR-34b-5p promotes the growth of
ALV-J-infected DF-1 cells by accelerating their proliferation and
migration.
MDA5 is a Direct Target of miR-34b-5p
Our previous RNA sequencing data (GSE63226) demonstrated
that MDA5 was significantly downregulated (P = 1.34E-06)
in the spleens of ALV-J-infected chickens compared to non-
infected chickens (Figure 3A). The RT-qPCR results revealed
that the expression of MDA5 was significantly downregulated
in immune system-related tissues including the livers (P =
0.046), spleens (P = 0.0022), and thymuses (P = 0.022)
of ALV-J-infected chickens compared to those from non-
infected chickens (Figure 3B). In addition, miR-34b-5p had
a contrasting expression pattern in ALV-J-infected chickens
compared to non-infected chickens (Figures 1, 3A,B). Using
miRNA target prediction software, miRDB (http://www.mirdb.
org/miRDB) (Wong and Wang, 2015), MDA5 was predicted
to be a potential target gene for miR-34b-5p. The miR-34b-5p
mature sequence and its binding seed sequence in MDA5 are
shown in Figure 3C. To confirm whether miR-34b-5p directly
targets the 3′ UTR of MDA5, a dual-luciferase reporter gene
assay was carried out in DF-1 cells. The transfection efficiency
analysis showed that 50 and 100 nM of an miR-34b-5p mimic
could significantly (P = 0.019) and highly significantly (P =
0.0027) decrease the MDA5 expression levels in DF-1 cells at
48 h after transfection, respectively (Figure 3D). Therefore, we
co-transfected 100 nM miR-34b-5p mimic or mi-NC into DF-1
cells with reporter vectors. The dual luciferase assay showed that
the wild-type group (WT-MDA5-3′UTR) induced a significant
decrease (P < 0.05) in luciferase activity compared to the control
group, whereas no significant difference was observed between
the mutant-type group (MT-MDA5-3′UTR) and control group
(Figure 3E). Taken together, these results suggested that MDA5
is a direct target of miR-34b-5p.
MDA5 Mediates the Effect of miR-34b-5p
on Cell Proliferation and Migration
To explore whether the effect of miR-34b-5p on cell processes
in ALV-J-infected cells was mediated by MDA5, we performed
CCK-8, cell cycle and wound healing assays in MDA5
overexpression and knockdown DF-1 cells. Overexpression of
MDA5 significantly inhibited (P ≤ 0.01) cell proliferation
compared to the control group at 24–120 h after the ALV-J
infection (Figure 4A). However,MDA5 knockdown significantly
promoted (P≤ 0.05) cell proliferation at 48–120 h after the ALV-J
infection (Figure 4B). On the other hand,MDA5 overexpression
significantly (P < 0.001) decreased the proportion of ALV-J-
infected cells at S phase but notably increased the proportion of
cells at G1 phase (P< 0.0001) and G2 phase (P< 0.05) compared
to the control group (Figure 4C). In contrast, knockdown of
MDA5 using siRNA led to a significant (P < 0.01) elevation
in the proportion of cells at S phase, and a clear reduction in
the proportion of cells at G1 phase (P < 0.05) or G2 phase (P
< 0.01; Figure 4D). Moreover, the migration rate of DF-1 cells
that overexpressedMDA5 was significantly decreased (P ≤ 0.01)
compared to that in the control group (Figures 4E,F). In contrast,
the migration rate of MDA5 knockdown cells was significantly
increased (P ≤ 0.01) compared to those transfected with the
small interfering RNA negative control (si-NC; Figures 4G,H).
These results indicated that miR-34b-5p might modulate the
proliferation, migration, and cell cycle of ALV-J-infected DF-1
cells by targetingMDA5.
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FIGURE 2 | Overexpression of miR-34b-5p promotes the proliferation and migration of ALV-J-infected DF-1 cells and it accelerates G1 to S phase
transition. Twelve hours after transfected with miR-34b-5p mimic or mi-NC, the transfected DF-1 cells were infected with ALV-J at TCID50. (A) Cell growth was
significantly increased after miR-34b-5p mimic transfection compared to the control cells (n = 6). (B) Overexpression of miR-34b-5p resulted in an increased
proportion of cells in the S phase and a decreased proportion of cells in the G2 phase. (C) Representative images of the wound healing assay at 0, 24, 48, and 72 h
after ALV-J infection in miR-34b-5p mimic or mi-NC transfected DF-1 cell. (D) Quantification of wound healing assay at 24, 48, and 72 h after ALV-J infection. In panel
A, the results were confirmed by three independent experiments with six (cell number) samples per treatment. In panels (B–D), each bar represents the mean ± the
SEM of three independent experiments. Asterisks denote statistically significant differences: *, **, and *** indicate P < 0.05, P < 0.01, and P < 0.001, respectively.
ALV-J, Avian leukosis virus subgroup J; mi-NC, mimic-negative control (empty plasmid); UTR, untranslated region; SEM, standard error of the mean; TCID50, 50%
tissue culture infectious dose.
MDA5 Can Detect ALV-J Infections and
Trigger the MDA5 Signaling Pathway
The ALV RNA genome has a typical slowly-transforming
replication-competent structure: 5′ R-U5-gag-pol-env-U3-R 3′
that contains three coding genes: Gag, Pol, and Env. The env gene
codes for an envelope glycoprotein that determines subgroup
specificity, neutralization, and receptor binding (Pan et al.,
2012). When miR-34b-5p was normal expression (Figure 5A),
the expression level ofMDA5 was upregulated (Figure 5B) at 16,
24, and 48 h after infection compared to at 2 h after infection.
In DF-1 cells infected with ALV-J, we found that the expression
of the Env, Gag and Pol mRNA was significantly upregulated
at 16, 24, and 48 h after infection compared to at 2 h after
infection (P < 0.05; Figures 5C–E). To investigate whether
chicken MDA5 signaling pathway was able to detect ALV-J
infections and then to initiate and amplify an innate immune
response, RT-qPCR was used to measure the changes in the
expression of innate and antiviral genes in the MDA5 signaling
pathway during ALV-J infections. The results showed that the
levels of all the mRNA, including those associated with IPS-1,
IRF-3, IFNβ, PKR, OAS,Mx1, andMHC class I were upregulated
at 24 and 48 h after infection compared to at 2 h after infection
(Figures 5F–L). In contrast, after overexpression of miR-34b-
5p by miRNA mimic (Supplementary Figure 1A) and following
inoculation with TCID50 of ALV-J, the expression level ofMDA5
was downregulated (Supplementary Figure 1B) in miR-34b-
5p overexpression DF-1 cells compared with negative control
(NC) group at 2-48 h ALV-J infection time points. In addition,
the mRNA expression of ALV-J related genes, including Env,
Gag and Pol (Supplementary Figures 1C–E, respectively) were
upregulated in miR-34b-5p overexpression DF-1 cells compared
with NC group during at 2–48 h ALV-J infection time points.
Moreover, the mRNA expression of MDA5 signaling pathway-
related innate and antiviral genes (IPS-1, IRF-3, IFNB, PKR, OAS,
MX1, MHC class 1) were downregulated compared with control
(Supplementary Figures 1F–L). These findings indicate that miR-
34b-5p suppresses MDA5 signaling pathway to promote ALV-J
replication.
To further elucidate the function of MDA5 on the MDA5
signaling pathway and ALV-J replication, ectopic expression, and
knockdown ofMDA5 was carried out in DF-1 cells. In DF-1 cells
that overexpressed MDA5, the mRNA and protein expression
of Env and the ALV-J virion secretion were significantly
suppressed (P ≤ 0.05) and the mRNA expression of genes in
the MDA5 signaling pathway was significantly upregulated (P
≤ 0.05; Figures 6A–D). In contrast, after knockdown of MDA5
by siRNA, the mRNA and protein expression of env were
upregulated (P < 0.05; Figures 6E,F). The expression of genes
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FIGURE 3 | MDA5 is a direct target of miR-34b-5p. (A) RNA sequencing showed that the expression of MDA5 was downregulated in the spleens of
ALV-J-infected chickens. (B) RT-qPCR showed that the expression of MDA5 was decreased in immune system-related tissues (including the liver, spleen, and thymus)
from ALV-J-infected chickens compared to those from non-infected chickens. (C) MiR-34b-5p binding site in the 3′ UTR of chicken MDA5 mRNA (in green). The
mutation sequence in the miR-34b-5p binding site is highlighted in blue. (D) 100 and 50 nM miR-34b-5p mimic could significantly decrease the expression of MDA5
mRNA in DF-1 cells at 48 h after transfection. (E) The luciferase assay was conducted by cotransfecting wildtype or mutant MDA5 3′ UTR with 100 nM miR-34b-5p
mimic or mi-NC into DF-1 cells. Firefly luciferase activity for each sample was normalized to Renilla luciferase activity. In all panels, the data shown are the mean ± the
SEM of three independent experiments. Asterisks denote statistically significant differences: *, **, ***, and **** indicate P < 0.05, P < 0.01, P < 0.001, and
P < 0.0001, respectively. ALV-J, Avian leukosis virus subgroup J; MDA5, melanoma differentiation-associated gene 5; mi-NC, mimic-negative control (empty plasmid);
UTR, untranslated region; RT-qPCR, real-time quantitative polymerase chain reaction; SEM: standard error of the mean.
in the MDA5 signaling pathway was significantly downregulated
(P ≤ 0.05), and sample-to-positive ratios of virion secretion in
the supernatants were elevated at 4 and 5 days after the infection
(P ≤ 0.05; Figures 6G,H). These data suggest that MDA5 can
recognize ALV-J infections and initiate and amplify an innate
immune response via the MDA5 signaling pathway in chickens.
MIR-34b-5p Modulates the MDA5 Signaling
Pathway and Promotes ALV-J Replication
As our findings suggested that miR-34b-5p might promote
the proliferation and migration of ALV-J-infected DF-1 cells
by targeting MDA5, we assessed the effects of miR-34b-5p
overexpression on the MDA5 signaling pathway to explore
the mechanism by which miR-34b-5p contributes to ALV-
J infections. In DF-1 cells that overexpressed miR-34b-
5p, the mRNA and protein expression level of Env were
significantly elevated 3 days after the infection (P < 0.01;
Figures 7A,B). Moreover, ectopic expression of miR-34b-5p
significantly inhibited the expression of genes in the MDA5
signaling pathway, including MDA5, IPS-1, IFNβ , OAS, Mx1,
and MHC class I (P ≤ 0.05), in ALV-J-infected DF-1 cells
(Figures 7A,C). The sample-to-positive ratio of virion secreted
in the supernatants was also significantly upregulated (P ≤
0.05) in DF-1 cells that overexpressed miR-34b-5p during ALV-
J infections (Figure 7D). These data indicate that miR-34b-5p
targets MDA5 to modulate the MDA5 signaling pathway and
further promote ALV-J replication.
DISCUSSION
We found that the expression of miR-34b-5p was increased
in ALV-J-infected tissues and that ectopic expression of miR-
34b-5p accelerated the proliferation and migration of ALV-
J-infected cells by targeting MDA5. In vitro experiments
revealed that the MDA5 signaling pathway, ALV-J related gene
expression, and virion secretion can be regulated by miR-
34b-5p. Accumulated evidence has indicated that miRNAs
are involved in tumor development, and aberrant miRNA
expression is closely associated with tumorigenesis (Zhang et al.,
2007; Asangani et al., 2008; Lovat et al., 2011; Tomasetti
et al., 2016). To date, several miRNAs, including gga-miR-
221, gga-miR-222, gga-miR-23b, gga-miR-375, gga-miR-125b,
gga-miR-1650, gga-miR-193a, gga-miR-193b, gga-let-7b, gga-let-
7i, gga-miR-458, gga-miR-1456, gga-miR-1704, gga-miR-1777,
gga-miR-1790, and gga-miR-2127, have been reported to be
associated with tumorigenesis and the aberrant expression of
the retrovirus, ALV-J (Li et al., 2012; Wang et al., 2013a,b;
Li H. et al., 2014; Dai et al., 2015; Li et al., 2015). Our
previous miRNA sequencing data indicated that miR-34b-
5p expression was increased in ALV-J-infected spleens. We
confirmed these results in the present study and discovered
that miR-34b-5p also was upregulated in other immune system-
related tissues.
MiR-34b-5p is a member of the miR-34 family. Previous
studies have suggested that members of the miR-34 family may
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FIGURE 4 | MDA5 mediates the effects of miR-34b-5p on the proliferation, cell cycle, and migration of ALV-J-infected DF-1 cells. (A) Cell growth was
significantly reduced after the transfection of an MDA5 overexpression plasmid compared to control cells (n = 6). (B) Cell growth was significantly increased after the
transfection of a siRNA targeted against the MDA5 gene compared to control cells (n = 6). (C) Overexpression of MDA5 resulted in increased proportions of cells in
the G1 and G2 phases and a decreased proportion of cells in the S phase. (D) Knockdown of MDA5 resulted in an increased proportion of cells in the S phase and
decreased proportions of cells in the G1 and G2 phases. (E) Representative images of the wound healing assay at 0, 24, 48, and 72 h after the ALV-J infections with
MDA5 overexpression in DF-1 cells. (F) Quantification of the wound healing assay of MDA5 overexpression at 24, 48, and 72 h after the ALV-J infections. (G)
Representative images of the wound healing assay at 0, 24, 48, and 72 h after the ALV-J infections in MDA5 knockdown DF-1 cells. (H) Quantification of the wound
healing assay in MDA5 knockdown DF-1 cells. In panels (A,B), the results were confirmed by three independent experiments with six (cell number) samples per
treatment. In panels (C,D,F,H), the data shown are the mean ± the SEM from three independent experiments. Asterisks denote statistically significant differences: *,
**, ***, and **** indicate P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively. ALV-J, Avian leukosis virus subgroup J; MDA5, melanoma
differentiation-associated gene 5; SEM, standard error of the mean; siRNA, small interfering RNA.
act as tumor suppressors (He et al., 2007; Hermeking, 2010).
However, most previous studies have been focused on two other
members of this family, miR-34a and miR-34c. It has been well-
documented that miR-34b-5p is involved in the regulation of
spermatogenesis (Smorag et al., 2012; Sakurai et al., 2015). In
addition, the miR-34b-5p/Notch1 pathway was reported to be
important for the oncogenesis involved in minimal deviation
adenocarcinoma (Lee H. et al., 2014). To our knowledge, this
study is the first study to demonstrate that miR-34b-5p may be
involved in the pathogenesis of ALV-J, as it appears to affect
many aspects of cancer biology, such as cell proliferationand
cell cycle progression. We further investigated the biological
functions of miR-34b-5p using an overexpression experiment
(Zhao et al., 2015; Shi B. et al., 2016). The functional investigation
demonstrated that ectopic expression of miR-34b-5p could
accelerate cell proliferation and migration in ALV-J-infected
cells. The cell cycle comprises three phases: G1, which involves
preparation for DNA synthesis; S, which involves DNA synthesis;
and G2, which involves preparation for mitosis (Zhang et al.,
2009). We found that miR-34b-5p overexpression increased the
proportion of cells in S phase and reduced the proportion of cells
in G2 phase, suggesting that it can induce cells from the G1 to the
S phase.
It is well-known that eachmiRNA can regulate up to hundreds
of target genes (Lewis et al., 2005). The use of prediction software
revealed that miR-34b-5p may have an effect on a large number
of target genes. Among these, three oncogenes, Notch1, c-Met,
and CDK6, have been confirmed to be targets of miR-34b-5p
(Smorag et al., 2012; Lee C. C. et al., 2014; Li et al., 2016).
We predicted that the MDA5 gene was a target of miR-34b-5p
using miRDB software and integrative analyses of our previous
RNA and small RNA sequencing data (GEO database, accession
numbers, GSE63226 and GSE63676, respectively). Subsequently,
we confirmed this prediction using RT-qPCR and a dual-
luciferase reporter assay.
The PRRs of host innate immune system, including Toll-like
receptors (TLRs), retinoic acid-inducible gene I-like helicases
(RLHs), and nucleotide-oligomerization domain-like receptors
(NLRs), can detect viral infections and evoke antiviral responses
by producing type I IFNs.MDA5 belongs to the RLH family and
it is able to detect viral RNA in the cytoplasm (Pichlmair et al.,
2006). The domain architecture of chicken MDA5 comprises
two caspase recruitment domains (CARDs), a restriction enzyme
domain type 3 (RES III), a helicase conserved C-terminal domain
(helicase-C), and a retinoic acid-inducible gene I C-terminal
regulatory domain (RIG-I-C-RD) (Lee et al., 2012) During a viral
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FIGURE 5 | The expression of mRNA of ALV-J env gag, pol and MDA5 signaling pathway-related innate and antiviral genes in chicken DF-1 cells
during ALV-J infections. DF-1 cells were infected with ALV-J at TCID50. The change in the expression of (A) miR-34b-5p, (B) MDA5, (C) Env, (D) gag, (E) Pol,
(F) IPS-1, (G) IRF-3, (H) IFNβ, (I) PKR, (J) OAS, (K) Mx1, and (L) MHC class I in ALV-J-infected DF-1 cells from 2 to 48 h after the infection. In all panels, each bar
represents the mean ± the SEM of three independent experiments. Asterisks denote statistically significant differences: *, **, ***, and **** indicate P < 0.05, P < 0.01,
P < 0.001, and P < 0.0001, respectively. ALV-J, Avian leukosis virus subgroup J; IFNβ, interferon-β; IPS-1, interferon-β promoter stimulator 1; IRF-3, interferon
regulatory factor-3; MDA5, melanoma differentiation-associated gene 5; MHC, major histocompatibility complex; Mx1, myxovirus (influenza virus) resistance 1,
interferon-inducible protein p78 (mouse); OAS, 2′, 5′-oligoadenylate synthetase; PKR, double-stranded RNA-dependent protein kinase; SEM, standard error of the
mean; TCID50, 50% tissue culture infectious dose.
infection, MDA5 detects viral RNA that has a helicase domain
and transmits a signal via CARDs. The activated CARDs associate
with an adaptor protein, IPS-1, and this leads to the recruitment
and activation of both canonical and non-canonical inhibitors
of NF-κB kinase (IKK) complexes. Furthermore, the activated
IKK complexes mediate the phosphorylation of IRF-3, which
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FIGURE 6 | MDA5 can detect ALV-J infections and trigger the MDA5 signaling pathway. The expression of ALV-J env (A) mRNA and (B) protein were
downregulated in DF-1 cells that overexpressed MDA5 3 days after the ALV-J infections. (C) The mRNA expression of MDA5 signaling pathway-related innate and
antiviral genes was upregulated in DF-1 cells that overexpressed MDA5. (D) The sample-to-positive ratio of virion secreted in the supernatants was downregulated in
DF-1 cells that overexpressed MDA5 (n = 6). The expression of ALV-J env (E) mRNA and (F) protein were upregulated in MDA5 knockdown DF-1 cells. (G) The mRNA
expression of MDA5 signaling pathway-related innate and antiviral genes was downregulated in MDA5 knockdown DF-1 cells. (H) The sample-to-positive ratio of
virion secreted in the supernatants was upregulated after MDA5 knockdown by siRNA (n = 6). In panels (A–C,E–G), the data shown are the mean ± the SEM from
three independent experiments. In panels (D,H), the results were confirmed by three independent experiments with six (cell number) samples per treatment. Asterisks
denote statistically significant differences: *, **, ***, and **** indicate P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively. ALV-J, Avian leukosis virus
subgroup J; MDA5, melanoma differentiation-associated gene 5; SEM, standard error of the mean; siRNA, small interfering RNA.
induces the formation of homodimers and/or heterodimers. The
functional IRF dimers translocate to the cell nucleus and interact
with IFN-stimulated response elements (ISREs), which leads to
the transcription of IFNβ and a set of IFN-inducible genes (PKR,
OAS, Mx1, and MHC class I; Kato et al., 2006; Takeuchi and
Akira, 2008; Karpala et al., 2011).
Our results showed that in the natural infection in tissues of
broilers caused by ALV-J, the expression level of miR-34b-5p was
aberrantly upregulated (Figures 1A,B); whereas, the expression
level of its target gene MDA5 was significantly down-regulated
(Figures 3A,B). On the other hand, in DF-1 cells infected ALV-
J, when miR-34b-5p was normally expressed (Figure 5A), the
expression level of MDA5 was up-regulated at 16 h, 24 h, 48 h
compared with 2 h after ALV-J infection (Figure 5B). These
differences in the expression levels could possibly be due to the
subject of time after ALV-J infection between the tissues (spleen)
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FIGURE 7 | Overexpression of miR-34b-5p suppresses the MDA5 signaling pathway and promotes ALV-J replication. The (A) mRNA and (B) protein
expression level of env were upregulated in DF-1 that overexpressed miR-34b-5p cells 3 days after the ALV-J infections. (C) The expression of mRNA of MDA5
signaling pathway-related innate and antiviral genes was downregulated in DF-1 cells that overexpressed miR-34b-5p. (D) The sample-to-positive ratio of virion
secreted in supernatants was upregulated in DF-1 cells that overexpressed miR-34b-5p (n = 6). In panels (A–C), the values are expressed as the mean ± the SEM of
three independent experiments. In panel (D), the results were confirmed by three independent experiments with six (cell number) samples per treatment. Asterisks
denote statistically significant differences: * and ** indicate P < 0.05 and P < 0.01, respectively. ALV-J, Avian leukosis virus subgroup J; MDA5, melanoma
differentiation-associated gene 5; SEM, standard error of the mean.
and DF-1 cells i.e., the time of spleen-infected broiler was longer
(140-day-old spontaneous infectious broilers) than those in DF-
1 cells infected for not more than 48 h. It has been reported that
the ALV-J viral stock could cause fibroblastic sarcoma in chickens
within 14 days but gave rise to a moderate transformation
in the culture of primary chicken embryonic fibroblast cells
(Wang et al., 2015). In order to confirm the assumption above,
we carried out miR-34b-5p mimic transfection in DF-1 and
then infected with ALV-J, after miR-34b-5p mimic transfection,
the RNA expression level of miR-34b-5p was significantly
upregulated than that in NC group (Supplementary Figure
1A). In addition, when miR-34b-5p was overexpressed, the
expression level of MDA5 was downregulated than that in NC
group (Supplementary Figure 1B). These results (ALV-J-infected
DF-1 cells with miR-34b-5p overexpression; Supplementary
Figure 1A,B) are consistent with natural ALV-J infection
broilers (Figures 1, 3A,B). Furthermore, we investigated the
mRNA expression level of ALV-J-related genes after miR-34b-
5p overexpressed in DF-1 cells; the mRNA expression level of
Env (Supplementary Figure 1C), Gag (Supplementary Figure 1D)
and Pol (Supplementary Figure 1E) were upregulated in ALV-
J-infected DF-1 cells compared with that in NC group at 2–
48 h ALV-J infection time points. Taken together, these data
suggest that miR-34b-5p could inhibit MDA5 to promote ALV-J
replication in DF-1 cells.
Moreover, we found that MDA5 plays an important role
in controlling the proliferation, cell cycle progression, and
migration of ALV-J-infected cells (Figure 4). Recently, antiviral
signaling pathways have attracted a great deal of attention
from researchers and there are many studies on the cellular
pathways involved in ALV-J infections. This research is necessary
to develop methods to control viral infections and/or help
to devise treatments for the infections. At present, several
pathways have been reported to play important roles in ALV-J
replication and infection, including the phosphoinositide 3-
kinase (PI3K)/AK mouse strain thymic lymphoma gene (Akt)
pathway, the ERK/ activator protein 1 (AP1) pathway, the
MAPK signaling pathway, the wingless-related integration site
(Wnt) signaling pathway, cytokine-cytokine receptor interaction,
the Janus kinase (JAK)/signal transducers and activators of
transcription (STAT) signaling pathway and the RLR signaling
pathway (Feng et al., 2011; Wang et al., 2013a; Dai et al.,
2016). We observed that MDA5 can affect the MDA5 signaling
pathway, and there was a clear correlation between this pathway
and virion secretion. These observations strongly indicate that
the MDA5 signaling pathway is involved in ALV-J replication.
In this study we proposed mechanism of miR-34b-5p actions
that mediated MDA5 signaling pathway during ALV-J infections
(Figure 8).
In conclusion, our findings revealed that miR-34b-5p was
increased in ALV-J-infected tissues and that ectopic expression of
miR-34b-5p accelerated the proliferation and migration of ALV-
J-infected cells and modulated cell cycle progression by targeting
MDA5. Further in vitro investigations revealed that miR-34b-5p
can regulate the MDA5 signaling pathway, ALV-J related gene
expression, and virion secretion. These results demonstrated
that miR-34b-5p targets MDA5 to inhibit the expression of
genes in the MDA5 signaling pathway (IPS-1, IRF-3, IFNβ,
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FIGURE 8 | A schematic representation showing the
miR-34b-5p-mediated MDA5 signaling pathway during ALV-J
infections. This model is based on knowledge of the MDA5-mediated
signaling pathway. As a member of the RLH family, MDA5 can detect ALV-J
infections in the cytoplasm. Abnormal expression of miR-34b-5p suppressed
the function of MDA5, which triggered the signal transduction cascade to
induce an IFNβ response and which, in turn, upregulated downstream antiviral
genes (PKR, OAS, Mx1, and MHC class I). MiR-34b-5p inhibited the
expression of MDA5, and led to increased proliferation and migration of the
ALV-J-infected cells, and promoted ALV-J replication. ALV-J, Avian leukosis
virus subgroup J; IFNβ, interferon-β; MDA5, melanoma
differentiation-associated gene 5; MHC, major histocompatibility complex;
Mx1, myxovirus (influenza virus) resistance 1, interferon-inducible protein p78
(mouse); OAS, 2′, 5′-oligoadenylate synthetase; PKR, double-stranded
RNA-dependent protein kinase; RLH, retinoic acid-inducible gene I-like
helicases.
PKR, OAS, Mx1, and MHC class I), accelerate the proliferation
and migration of ALV-J-infected cells and promote ALV-J
replication (Figure 8). These findings provide a solid foundation
for the understanding of the underlying mechanisms of ALV-
J pathogenesis and they will contribute to the development of
studies on other retroviruses.
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